89 related articles for article (PubMed ID: 406041)
1. Intravesical and systemic chemotherapy of murine bladder cancer.
Soloway MS
Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
[No Abstract] [Full Text] [Related]
2. Enhanced anti-tumor immunity of vaccine combined with anti-PD-1 antibody in a murine bladder cancer model.
Lim S; Park JH; Chang H
Investig Clin Urol; 2023 Jan; 64(1):74-81. PubMed ID: 36629068
[TBL] [Abstract][Full Text] [Related]
3. Establishment of an optimized orthotopic bladder cancer model in mice.
Cai J; Xie Z; Yan Y; Huang Z; Tang P; Cao X; Wang Z; Yang C; Tan M; Zhang F; Shen B
BMC Urol; 2022 Sep; 22(1):142. PubMed ID: 36057655
[TBL] [Abstract][Full Text] [Related]
4. Animal Models in Bladder Cancer.
Constantin T; Păvălean M; Bucur Ș; Constantin MM; Nicolescu AC; Pacu I; Mădan V
Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944577
[TBL] [Abstract][Full Text] [Related]
5. An oral cancer vaccine using a
Kitagawa K; Tatsumi M; Kato M; Komai S; Doi H; Hashii Y; Katayama T; Fujisawa M; Shirakawa T
Mol Ther Oncolytics; 2021 Sep; 22():592-603. PubMed ID: 34589578
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
Kerzeli IK; Lord M; Doroszko M; Elgendy R; Chourlia A; Stepanek I; Larsson E; van Hooren L; Nelander S; Malmstrom PU; Dragomir A; Segersten U; Mangsbo SM
PLoS One; 2021; 16(7):e0253178. PubMed ID: 34232958
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Mouse Cancer/Testis Antigen Functions in Cancer Cells and Roles of TEKT5 in Cancer Cells and Testicular Germ Cells.
Aoki N; Matsui Y
Mol Cell Biol; 2019 Sep; 39(17):. PubMed ID: 31208979
[TBL] [Abstract][Full Text] [Related]
8. How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model.
Erman A; Kapun G; Novak S; Pavlin M; Dražić G; Drobne D; Veranič P
Histochem Cell Biol; 2019 Mar; 151(3):263-273. PubMed ID: 30280243
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.
Zuiverloon TCM; de Jong FC; Costello JC; Theodorescu D
Bladder Cancer; 2018 Apr; 4(2):169-183. PubMed ID: 29732388
[TBL] [Abstract][Full Text] [Related]
10. Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.
John BA; Said N
Oncotarget; 2017 Aug; 8(34):57766-57781. PubMed ID: 28915710
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Control of Bladder-Associated Tumors Using Shrimp Anti-Lipopolysaccharide Factor (SALF) Antimicrobial Peptide as a Cancer Vaccine Adjuvant in Mice.
Huang HN; Rajanbabu V; Pan CY; Chan YL; Chen JY; Wu CJ
Mar Drugs; 2015 May; 13(5):3241-58. PubMed ID: 26006716
[TBL] [Abstract][Full Text] [Related]
12. Current animal models of bladder cancer: Awareness of translatability (Review).
Ding J; Xu D; Pan C; Ye M; Kang J; Bai Q; Qi J
Exp Ther Med; 2014 Sep; 8(3):691-699. PubMed ID: 25120584
[TBL] [Abstract][Full Text] [Related]
13. Landmarks in non-muscle-invasive bladder cancer.
Mertens LS; Neuzillet Y; Horenblas S; van Rhijn BW
Nat Rev Urol; 2014 Aug; 11(8):476-80. PubMed ID: 24980189
[TBL] [Abstract][Full Text] [Related]
14. Role of Rip2 in development of tumor-infiltrating MDSCs and bladder cancer metastasis.
Zhang H; Chin AI
PLoS One; 2014; 9(4):e94793. PubMed ID: 24733360
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway.
Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chi BH; Chang IH
J Korean Med Sci; 2014 Mar; 29(3):343-50. PubMed ID: 24616582
[TBL] [Abstract][Full Text] [Related]
16. A new method of establishing orthotopic bladder transplantable tumor in mice.
Yang XH; Ren LS; Wang GP; Zhao LL; Zhang H; Mi ZG; Bai X
Cancer Biol Med; 2012 Dec; 9(4):261-5. PubMed ID: 23691487
[TBL] [Abstract][Full Text] [Related]
17. Tumor establishment features of orthotopic murine bladder cancer models.
Lee JS; Bae MH; Choi SH; Lee SH; Cho YS; Park HJ; Kwon CH; Joo KJ
Korean J Urol; 2012 Jun; 53(6):396-400. PubMed ID: 22741047
[TBL] [Abstract][Full Text] [Related]
18. Exploring molecular genetics of bladder cancer: lessons learned from mouse models.
Ahmad I; Sansom OJ; Leung HY
Dis Model Mech; 2012 May; 5(3):323-32. PubMed ID: 22422829
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of recurrence of Ta/T1 bladder cancer.
Bryan RT; Collins SI; Daykin MC; Zeegers MP; Cheng KK; Wallace DM; Sole GM
Ann R Coll Surg Engl; 2010 Sep; 92(6):519-24. PubMed ID: 20522307
[TBL] [Abstract][Full Text] [Related]
20. Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments.
Horiguchi Y; Kikuchi E; Ozu C; Nishiyama T; Oyama M; Horinaga M; Yoshioka K; Tachibana M
Hum Cell; 2008 Aug; 21(3):57-63. PubMed ID: 18667021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
